Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) P/B ratio
As of 16 October 2026, Intuitive Surgical, Inc. (ISRG) trades at a P/B ratio of 8.3×. Over the past ten years it has ranged from 4.1× (October 2015) to 13.1× (January 2025); the current reading is higher than 42% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 11.3× | 0.44% |
| FY2024 | 11.2× | 29.27% |
| FY2023 | 8.7× | 2.05% |
| FY2022 | 8.5× | (20.58%) |
| FY2021 | 10.7× | 9.12% |
| FY2020 | 9.8× | 19.15% |
| FY2019 | 8.2× | 1.13% |
| FY2018 | 8.1× | (7.13%) |
| FY2017 | 8.8× | 106.10% |
| FY2016 | 4.3× | (9.30%) |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 7.7× | (17.22%) |
| Mar 2026 | 9.3× | (17.48%) |
| Dec 2025 | 11.3× | 20.39% |
| Sep 2025 | 9.4× | (13.76%) |
| 42 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| ALC Alcon compare | 1.5× |
| MDLN Medline Inc. compare | 1.6× |
| BAX Baxter International Inc. compare | 2.1× |
| BDX Becton, Dickinson and Company compare | 2.2× |
| SOLV Solventum Corporation compare | 3.1× |
| RGEN Repligen Corporation compare | 4.7× |
| RMD ResMed Inc. compare | 5.3× |
| ISRG Intuitive Surgical, Inc. | 8.3× |
| WST West Pharmaceutical Services, Inc. compare | 9.1× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement